Search Results (2)

Hypoxis hemerocallidea (Hypoxidaece) is thoroughly researched and well documented for its plethora of anecdotal and scientifically backed pharmacological potentials. Its anecdotal uses and pharmacological activities are attributed to its extract’s inherent bioactive compounds like hypoxoside, rooperol, and β-sitosterol. This study aimed at conducting a targeted and holistic phytochemical profiling of variations in Hypoxis hemerocallidea (H. hemerocallidea) and related species. The chemotaxonomic classifications of H. hemerocallidea and seven other related species were also carried out to avert the possibility of over harvesting H. hemerocallidea and the encouragement of species inter-change. The plant extracts were analysed with reverse phase ultra-pure liquid chromatography quadrupole time-of-flight mass spectrometry and gas chromatography, as well as high-performance thin-layer chromatography. The generated chromatographic data were made compatible for chemometric computation using Principal Component Analysis (PCA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) models. The results obtained unveil orcinol glycoside, curculigoside C, hypoxoside, dehydroxyhypoxoside, bisdehydroxy hypoxoside, hemerocalloside, galpinoside, cholchicoside, geraniol glycoside, β-sitosterol, oleic acid, and 2-hydroxyethyl linoleate as target phytochemicals that define the profiles of the Hypoxis species. In addition, three distinct chemotypes defined by hemerocalloside, galpinoside, and colchicoside, respectively, were observed, as well as holistic variations in all secondary metabolites. Due to similarities in the phytochemical constituents of selected species, species inter-change seems imminent if further research confirms the findings of this study. Full article

The reducing potential of plant extracts in the green synthesis of nanoparticles has been associated with their phytochemicals. Although pharmacologically inactive, a norlignan diglucoside “hypoxoside” (HP) occurs in large quantities in the extract of Hypoxis hemerocallidea (HE). In this work, HP was isolated from HE where both were used in the biosynthesis of the corresponding silver nanoparticles (HP-AgNPs and HE-AgNPs). The AgNPs were fully characterized using various physicochemical techniques and their antimicrobial and anticancer properties were evaluated. Transmission electron microscopy (TEM) revealed sizes of 24.3 ± 4 nm for the HE-AgNPs and 3.9 ± 1.6 nm for the HP-AgNPs. The HE-AgNPs demonstrated enhanced anti-bactericidal effects on Escherichia coli and Salmonella enterica with a minimum inhibitory concentration (MIC) value of 1.95 µg/mL, competing well with the standard drug. The cytotoxic activity showed that the HE-AgNPs reduced cell viability with an IC50 of 0.81 and 4.0 µg/mL, respectively, for the U87 and U251 cells, while the HP-AgNPs displayed 0.20 and 0.55 µg/mL for both cell lines, respectively. Furthermore, while the HE-AgNPs were selective to U87 alone, the HP-AgNPs were selective to both glioblastoma cells tested. The study demonstrated the ability of a single phytoconstituent (hypoxoside), not only as the chief bioreductant in the extract, but also as a standalone reducing and capping agent, producing ultra-small, spherical, and monodispersed AgNPs with enhanced biological properties. Full article